Back

Effect of drug treatment on quality of life in heart failure with preserved ejection fraction: a systematic review and meta-analysis of randomised controlled trials

29 April 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 3 - HFpEF - Heart failure with preserved ejection fraction HFpEF - Heart failure with preserved ejection fraction HFA Premium Access Heart Failure 2017 - 4th World Congress on Acute Heart Failure

About the speaker

Photo
Doctor Sean Zheng

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)

16 More presentations in this session

Presentation thumbnail
Prognostic impact of blood pressure values in patients with heart failure with preserved ejection fraction
Doctor M. Goncalves (Viseu, PT)
Abstract
Presentation thumbnail
Exercise training in diastolic heart failure (Ex-DHF): rationale and design of a multicentre, prospective, randomized, controlled, parallel group trial
Doctor A. Feuerstein (Berlin, DE)
Abstract
Presentation thumbnail
Left atrial volume index predicts major adverse cardiovascular events in patients with ischemic chronic heart failure with preserved ejection fraction and renal dysfunction
Professor D. Lashkul (Zaporizhzhya, UA)
Presentation thumbnail
The comorbidity in patients with heart failure and preserved ejection fraction depending on age
Presentation thumbnail
Machine-learning based exploration of variability of longitudinal myocardial velocities in heart failure with preserved ejection fraction
Professor B. Bijnens (Badalona, ES)
Abstract Slides

Access the full session

Session thumbnail
Poster session 3 - HFpEF - Heart failure with preserved ejection fraction

The Event

Event poster

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources